Charlottesville North Dialysis is a medicare approved dialysis facility center in Charlottesville, Virginia and it has 13 dialysis stations. It is located in Albemarle county at 1800 Timberwood Blvd Ste C, Charlottesville, VA, 22911. You can reach out to the office of Charlottesville North Dialysis at (434) 973-8555. This dialysis clinic is managed and/or owned by Davita. Charlottesville North Dialysis has the following ownership type - Profit. It was first certified by medicare in July, 2006. The medicare id for this facility is 492636 and it accepts patients under medicare ESRD program.
| Name | Charlottesville North Dialysis |
|---|---|
| Location | 1800 Timberwood Blvd Ste C, Charlottesville, Virginia |
| No. of Dialysis Stations | 13 |
| Medicare ID | 492636 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1800 Timberwood Blvd Ste C, Charlottesville, Virginia, 22911 | |
| (434) 973-8555 | |
News Archive
Rewarding health care organizations for achieving large-scale, population-based improvement has significant potential to accelerate the spread of evidence-based interventions, improve quality, and control costs at a national level, according to a commentary in the February 17 issue of the Journal of the American Medical Association.
A USA TODAY analysis of more than 4,600 U.S. hospitals has found that 120 of those most highly rated by patients have higher than average death rates for heart attack, heart failure or pneumonia. More than a dozen of these hospitals have high death rates for at least two of those conditions.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.
› Verified 1 days ago
| NPI Number | 1700844859 |
| Organization Name | Charlottesville North Dialysis |
| Doing Business As | Dva Renal Healthcare Inc |
| Address | 1800 Timberwood Blvd Charlottesville, Virginia, 22911 |
| Phone Number | (434) 973-8555 |
News Archive
Rewarding health care organizations for achieving large-scale, population-based improvement has significant potential to accelerate the spread of evidence-based interventions, improve quality, and control costs at a national level, according to a commentary in the February 17 issue of the Journal of the American Medical Association.
A USA TODAY analysis of more than 4,600 U.S. hospitals has found that 120 of those most highly rated by patients have higher than average death rates for heart attack, heart failure or pneumonia. More than a dozen of these hospitals have high death rates for at least two of those conditions.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 24 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 25 |
News Archive
Rewarding health care organizations for achieving large-scale, population-based improvement has significant potential to accelerate the spread of evidence-based interventions, improve quality, and control costs at a national level, according to a commentary in the February 17 issue of the Journal of the American Medical Association.
A USA TODAY analysis of more than 4,600 U.S. hospitals has found that 120 of those most highly rated by patients have higher than average death rates for heart attack, heart failure or pneumonia. More than a dozen of these hospitals have high death rates for at least two of those conditions.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 29 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 268 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Rewarding health care organizations for achieving large-scale, population-based improvement has significant potential to accelerate the spread of evidence-based interventions, improve quality, and control costs at a national level, according to a commentary in the February 17 issue of the Journal of the American Medical Association.
A USA TODAY analysis of more than 4,600 U.S. hospitals has found that 120 of those most highly rated by patients have higher than average death rates for heart attack, heart failure or pneumonia. More than a dozen of these hospitals have high death rates for at least two of those conditions.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Charlottesville North Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 35 |
| Hypercalcemia patient months | 335 |
| Patients with Serumphosphor | 35 |
| Patients with Serumphosphor less than 3.5 mg/dL | 12 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 36 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 12 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
Rewarding health care organizations for achieving large-scale, population-based improvement has significant potential to accelerate the spread of evidence-based interventions, improve quality, and control costs at a national level, according to a commentary in the February 17 issue of the Journal of the American Medical Association.
A USA TODAY analysis of more than 4,600 U.S. hospitals has found that 120 of those most highly rated by patients have higher than average death rates for heart attack, heart failure or pneumonia. More than a dozen of these hospitals have high death rates for at least two of those conditions.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 34 |
| Patient months included in arterial venous fistula and catheter summaries | 305 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 71 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 15 |
News Archive
Rewarding health care organizations for achieving large-scale, population-based improvement has significant potential to accelerate the spread of evidence-based interventions, improve quality, and control costs at a national level, according to a commentary in the February 17 issue of the Journal of the American Medical Association.
A USA TODAY analysis of more than 4,600 U.S. hospitals has found that 120 of those most highly rated by patients have higher than average death rates for heart attack, heart failure or pneumonia. More than a dozen of these hospitals have high death rates for at least two of those conditions.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 32 |
| Hospitalization Rate in facility | 84.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 229.9 |
| Hospitalization Rate: Lower Confidence Limit | 33.4 |
News Archive
Rewarding health care organizations for achieving large-scale, population-based improvement has significant potential to accelerate the spread of evidence-based interventions, improve quality, and control costs at a national level, according to a commentary in the February 17 issue of the Journal of the American Medical Association.
A USA TODAY analysis of more than 4,600 U.S. hospitals has found that 120 of those most highly rated by patients have higher than average death rates for heart attack, heart failure or pneumonia. More than a dozen of these hospitals have high death rates for at least two of those conditions.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Charlottesville North Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 10.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 32.3 |
| Readmission Rate: Lower Confidence Limit | 1.5 |
News Archive
Rewarding health care organizations for achieving large-scale, population-based improvement has significant potential to accelerate the spread of evidence-based interventions, improve quality, and control costs at a national level, according to a commentary in the February 17 issue of the Journal of the American Medical Association.
A USA TODAY analysis of more than 4,600 U.S. hospitals has found that 120 of those most highly rated by patients have higher than average death rates for heart attack, heart failure or pneumonia. More than a dozen of these hospitals have high death rates for at least two of those conditions.
Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.
The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.
› Verified 1 days ago